Coronavirus vaccine could mean $15B 'windfall' for Pfizer: Report

The U.S. government has already put in an order for 100 million doses of an experimental COVID-19 vaccine being developed by Pfizer and BioNTech for $1.95 billion, with an option for 500 million more doses.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.